Dr. Michael Tees, MD
Claim this profileColorado Blood Cancer Institute
Studies Lymphoma
Studies Non-Hodgkin's Lymphoma
7 reported clinical trials
10 drugs studied
Area of expertise
1Lymphoma
ALK
CCND1 positive
t(11;14) positive
2Non-Hodgkin's Lymphoma
BCL2 positive
BCL6 positive
MYC positive
Affiliated Hospitals
Clinical Trials Michael Tees, MD is currently running
CAR T-Cell Therapy
for Non-Hodgkin's Lymphoma
A Phase 1/2 Study of bbT369, a dual targeting CAR T cell drug product with a gene edit, in Relapsed and/or Refractory B cell Non-Hodgkin's Lymphoma.
Recruiting1 award Phase 1 & 2
CAR NK Cells
for B-Cell Cancers
This is a single arm, open-label, multi-center, Phase 1 study to determine the safety and tolerability of an experimental therapy called NKX019 (allogeneic CAR NK cells targeting CD19) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL) or B cell acute lymphoblastic leukemia (B-ALL)
Recruiting1 award Phase 114 criteria
More about Michael Tees, MD
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Michael Tees, MD has experience with
- Epcoritamab
- GEN3009
- CRG-022
- Elotuzumab
- Dexamethasone
- Pomalidomide
Breakdown of trials Michael Tees, MD has run
Lymphoma
Non-Hodgkin's Lymphoma
B-Cell Lymphoma
Mantle Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Tees, MD specialize in?
Michael Tees, MD focuses on Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved ALK patients, or patients who are CCND1 positive.
Is Michael Tees, MD currently recruiting for clinical trials?
Yes, Michael Tees, MD is currently recruiting for 3 clinical trials in Denver Colorado. If you're interested in participating, you should apply.
Are there any treatments that Michael Tees, MD has studied deeply?
Yes, Michael Tees, MD has studied treatments such as Epcoritamab, GEN3009, CRG-022.
What is the best way to schedule an appointment with Michael Tees, MD?
Apply for one of the trials that Michael Tees, MD is conducting.
What is the office address of Michael Tees, MD?
The office of Michael Tees, MD is located at: Colorado Blood Cancer Institute, Denver, Colorado 80218 United States. This is the address for their practice at the Colorado Blood Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.